Company / Operating Income per Share
Gain Therapeutics, Inc. Operating Income per Share History
FY2021-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.37
FY2024
5-year range
-$1.50 / -$0.98
FY2021-FY2024
Trend
+8.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share returned to growth in FY2024 after 2 years of decline, reaching $-1.37.
Based on SEC 10-K filings.
-1.37 in FY2024.
Declined from $-1.16 to $-1.37 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share increased 8.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -16.87 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$1.37 | +8.2% |
| FY2023 | -$1.50 | -28.6% |
| FY2022 | -$1.16 | -18.5% |
| FY2021 | -$0.98 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026